These results not only suggested that the downregulation of UBE2C could significantly inhibit the proliferation of tumor cells, but also confirmed that KAT2A and E2F1 could indeed affect the proliferation of tumor cells through regulating the expression of UBE2C. This evidence concerns the gene KAT2A and neoplasm.